Joint Research Management Office

Performing research menu

SOP 26b

SOP 26b - Pharmacovigilance and safety reporting for sponsored non-CTIMPs [PDF 92KB]


This SOP is currently under review by the JRMO. Please note the JRMO have agreed that point 9 is inaccurate and will be amended.  

  • With immediate effect the sponsor must review the draft APR prior to REC/HRA submission.


Please note that the correct email address for reporting safety matters is now 



Return to top